+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dermatology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5292750
  • Report
  • February 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Allergan Plc
  • Galderma S.A
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
Dermatology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Dermatology Drugs market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider dermatology drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The dermatology drugs market section of the report gives context. It compares the dermatology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, dermatology drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Johnson & Johnson; Allergan Plc; Galderma S.A; Novartis AG; GlaxoSmithKline Plc

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, dermatology drugs indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc
  • Galderma S.A
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
1. Executive Summary

2. Report Structure

3. Dermatology Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Dermatology Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Dermatology Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Dermatology Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Dermatology Drugs Market Trends and Strategies

8. Impact of COVID-19 on Dermatology Drugs

9. Dermatology Drugs Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. Dermatology Drugs Market Regional Analysis
10.1. Global Dermatology Drugs Market, 2020, by Region, Value ($ Billion)
10.2. Global Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global Dermatology Drugs Market, Growth and Market Share Comparison, by Region

11. Dermatology Drugs Market Segmentation
11.1. Global Dermatology Drugs Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Acne
  • Dermatitis
  • Psoriasis
  • Other Drugs for Dermatology Diseases
11.2. Global Dermatology Drugs Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
11.3. Global Dermatology Drugs Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
11.4. Global Dermatology Drugs Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
11.5. Global Dermatology Drugs Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
12. Dermatology Drugs Market Metrics
12.1. Dermatology Drugs Market Size, Percentage of GDP, 2015-2025, Global
12.2. Per Capita Average Dermatology Drugs Market Expenditure, 2015-2025, Global

13. Asia-Pacific Dermatology Drugs Market
13.1. Asia-Pacific Dermatology Drugs Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. Asia-Pacific, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
13.3. Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
13.4. Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
13.5. Asia-Pacific, Dermatology Drugs Market Metrics
13.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
13.6. Asia-Pacific Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Dermatology Drugs Market: Country Analysis
13.7.1. China Dermatology Drugs Market
13.7.1.1. China Dermatology Drugs Market Overview
13.7.1.2. China Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.1.3. China Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2. Australia Dermatology Drugs Market
13.7.2.1. Australia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Dermatology Drugs Market
13.7.3.1. Hong Kong Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4. India Dermatology Drugs Market
13.7.4.1. India Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4.2. India Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Dermatology Drugs Market
13.7.5.1. Indonesia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6. Japan Dermatology Drugs Market
13.7.6.1. Japan Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Dermatology Drugs Market
13.7.7.1. Malaysia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Dermatology Drugs Market
13.7.8.1. New Zealand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Dermatology Drugs Market
13.7.9.1. Philippines Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Dermatology Drugs Market
13.7.10.1. Singapore Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Dermatology Drugs Market
13.7.11.1. South Korea Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Dermatology Drugs Market
13.7.12.1. Thailand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Dermatology Drugs Market
13.7.13.1. Vietnam Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe Dermatology Drugs Market
14.1. Western Europe Dermatology Drugs Market Overview
14.2. Western Europe, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
14.3. Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Western Europe, Dermatology Drugs Market Metrics
14.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Western Europe Countries
14.6. Western Europe Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Western Europe Dermatology Drugs Market: Country Analysis
14.7.1. Austria Dermatology Drugs Market
14.7.1.1. Austria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Dermatology Drugs Market
14.7.2.1. Belgium Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Dermatology Drugs Market
14.7.3.1. Denmark Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. Finland Dermatology Drugs Market
14.7.4.1. Finland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. France Dermatology Drugs Market
14.7.5.1. France Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. France Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Germany Dermatology Drugs Market
14.7.6.1. Germany Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Dermatology Drugs Market
14.7.7.1. Ireland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. Italy Dermatology Drugs Market
14.7.8.1. Italy Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Dermatology Drugs Market
14.7.9.1. Netherlands Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Norway Dermatology Drugs Market
14.7.10.1. Norway Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Dermatology Drugs Market
14.7.11.1. Portugal Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Spain Dermatology Drugs Market
14.7.12.1. Spain Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Dermatology Drugs Market
14.7.13.1. Sweden Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Dermatology Drugs Market
14.7.14.1. Switzerland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15. UK Dermatology Drugs Market
14.7.15.1. UK Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe Dermatology Drugs Market
15.1. Eastern Europe Dermatology Drugs Market Overview
15.2. Eastern Europe, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
15.3. Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Eastern Europe, Dermatology Drugs Market Metrics
15.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Eastern Europe Countries
15.6. Eastern Europe Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Dermatology Drugs Market: Country Analysis
15.7.1. Czech Republic Dermatology Drugs Market,
15.7.1.1. Czech Republic Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Poland Dermatology Drugs Market
15.7.2.1. Poland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Romania Dermatology Drugs Market
15.7.3.1. Romania Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Russia Dermatology Drugs Market
15.7.4.1. Russia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America Dermatology Drugs Market
16.1. North America Dermatology Drugs Market Overview
16.2. North America, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
16.3. North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. North America, Dermatology Drugs Market Metrics
16.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, North America Countries
16.6. North America Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. North America Dermatology Drugs Market: Country Analysis
16.7.1. Canada Dermatology Drugs Market
16.7.1.1. Canada Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Dermatology Drugs Market
16.7.2.1. Mexico Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. USA Dermatology Drugs Market
16.7.3.1. USA Dermatology Drugs Market Overview
16.7.3.2. USA Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America Dermatology Drugs Market
17.1. South America Dermatology Drugs Market Overview
17.2. South America, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
17.3. South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. South America, Dermatology Drugs Market Metrics
17.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, South America Countries
17.6. South America Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. South America Dermatology Drugs Market: Country Analysis
17.7.1. Argentina Dermatology Drugs Market
17.7.1.1. Argentina Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Dermatology Drugs Market
17.7.1.1. Brazil Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. Chile Dermatology Drugs Market
17.7.3.1. Chile Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Dermatology Drugs Market
17.7.4.1. Colombia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.5. Peru Dermatology Drugs Market
17.7.5.1. Peru Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Dermatology Drugs Market
17.7.6.1. Venezuela Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East Dermatology Drugs Market
18.1. Middle East Dermatology Drugs Market Overview
18.2. Middle East, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
18.3. Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. Middle East, Dermatology Drugs Market Metrics
18.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Middle East Countries
18.6. Middle East Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. Middle East Dermatology Drugs Market: Country Analysis
18.7.1. Saudi Arabia Dermatology Drugs Market
18.7.1.1. Saudi Arabia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Israel Dermatology Drugs Market
18.7.2.1. Israel Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Dermatology Drugs Market
18.7.3.1. Turkey Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. UAE Dermatology Drugs Market
18.7.4.1. UAE Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa Dermatology Drugs Market
19.1. Africa Dermatology Drugs Market Overview
19.2. Africa, Dermatology Drugs Market, 2020, by Country, Value ($ Billion)
19.3. Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Africa, Dermatology Drugs Market Metrics
19.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Africa Countries
19.6. Africa Dermatology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Africa Dermatology Drugs Market: Country Analysis
19.7.1. Egypt Dermatology Drugs Market
19.7.1.1. Egypt Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Dermatology Drugs Market
19.7.2.1. Nigeria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Dermatology Drugs Market
19.7.3.1. South Africa Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Dermatology Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Johnson & Johnson
20.3.1.1. Company Overview
20.3.1.2. Products and Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Allergan Plc
20.3.2.1. Company Overview
20.3.2.2. Products and Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Galderma S.A
20.3.3.1. Company Overview
20.3.3.2. Products and Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. Novartis AG
20.3.4.1. Company Overview
20.3.4.2. Products and Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. GlaxoSmithKline Plc
20.3.5.1. Company Overview
20.3.5.2. Products and Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers and Acquisitions in the Dermatology Drugs Market

22. Market Background: Pharmaceutical Drugs Market
22.1. Pharmaceutical Drugs Market Characteristics
22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global
22.3. Global Pharmaceutical Drugs Market, 2020, by Region, Value ($ Billion)
22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion)

23. Recommendations
23.1. Global Dermatology Drugs Market in 2025 - Growth Countries
23.2. Global Dermatology Drugs Market in 2025 - Growth Segments
23.3. Global Dermatology Drugs Market in 2025 - Growth Strategies

24. Appendix
24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc
  • Galderma S.A
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
Major companies in the dermatology drugs market include Johnson & Johnson; Allergan Plc; Galderma S.A; Novartis AG and GlaxoSmithKline Plc.

The global dermatology drugs market is expected to grow from $37.57 billion in 2020 to $40.49 billion in 2021 at a compound annual growth rate (CAGR) of 7.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $62.83 billion in 2025 at a CAGR of 12%.

The dermatology drugs market consists of sales of dermatology drugs by entities (organizations, sole traders and partnerships) that produce dermatology drugs to treat skin diseases. This industry includes establishments that produce drugs to treat diseases such as rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections and other skin disorders. The dermatology market is segmented into acne; dermatitis; psoriasis; and other drugs for dermatology diseases.

Asia Pacific was the largest region in the global dermatology drugs market, accounting for 36% of the market in 2020. North America was the second largest region accounting for 27% of the global dermatology drugs market. Africa was the smallest region in the global dermatology drugs market.

Drug manufacturing companies are using genome testing (genetic diagnosis) to reduce the time and costs spent in clinical trials. A clinical trial is a complex process and it often takes months for a drug to be available in the market. This deprives patients of cost-effective treatment. Researchers in the Rockefeller University used genomic testing and data analytics to predict the response of psoriasis patients for a given treatment. Genomic testing algorithms collect gene-expression data from skin biopsies and detect activity in 50,000 different genes. This technique can predict the response of a patient with an accuracy of 95% and within 12 weeks, thus saving significant time for clinical trials and the launch of new drugs.

High costs associated with drugs is a major issue faced by citizens of many countries. Pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, the pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of dermatology drugs manufacturers.

The dermatology drugs market was mainly driven by rapid growth in emerging markets in the historic period. Emerging markets growth was aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP grew from $11 trillion in 2015 to $13.6 trillion in 2018. Additionally, according to the World Economic Outlook Reports by the IMF, emerging markets and developing economies together registered a growth of 4.0% in 2015 and this increased to 4.5% in 2018. Thus, strong economic growth boosted the demand for dermatology drugs and this drove the market during the historic period.
Note: Product cover images may vary from those shown
  • Johnson & Johnson
  • Allergan Plc
  • Galderma S.A
  • Novartis AG
  • GlaxoSmithKline Plc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll